Home
Conditions
Opportunistic Infections

Clinical trial condition

Opportunistic Infections

Explore clinical trials studying Opportunistic Infections. Study availability and eligibility vary by location and protocol.

35 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Opportunistic Infections trial results

Completed

Validation of a Risk Score Opportunistic Infections Development in Kidney Transplant Patients

NCT03083756

Conditions: Infections, Opportunistic Infections
Locations: Complejo Hospitalario Universitario A Coruña A Coruña, Spain

Hospital Son Espases Palma de Mallorca, Balearic Islands, Spain

Hospital del Mar Barcelona, Spain

Hospital Vall d´Hebrón Barcelona, Spain

View all 15 locations

View Trial Details

Completed

Tecfidera Lymphocyte Chart Review

NCT02519413

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Research site Homewood, Alabama, United States

Research Site Newport Beach, California, United States

Research Site Atlanta, Georgia, United States

Research Site Buffalo, New York, United States

View Trial Details

Completed

Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation

NCT02337595

Conditions: Bone Marrow Diseases, Bone Marrow Failure Disorders, Bone Marrow Failure Syndromes, +18 more
Locations: Federal Research Center for pediatric hematology, oncology and immunology Moscow, Russia

View Trial Details

Completed

Prediction and Pathogenesis of the Immune Reconstitution Inflammatory Syndrome

NCT01557803

Conditions: Immune Reconstitution Inflammatory Syndrome, Immune System Diseases, Infections, +1 more
Locations: Medical Research Unit - Albert Schweitzer Hospital Lambaréné, Moyen Ogoué, Gabon

View Trial Details

Completed

Antiretroviral Therapy for Advanced HIV Disease in South Africa

NCT00342355

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations: South African Military Health Services (SAMHS) Centurion, South Africa

Umtata Sickbay Eastaern Cape, South Africa

3 Military Hospital Free State, South Africa

1 Military Hospital Gauteng, South Africa

View Trial Details

Completed

Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons

NCT00463086

Conditions: Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +23 more
Locations: Ubuntu Clinic,Site B Khayelitsha Cape Town, Western Cape, South Africa

View Trial Details

Completed

Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation

NCT00402532

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +7 more
Locations: Hannover Medical School, Division of Thoracic and Cardiovascular Surgery Hanover, Germany

View Trial Details

Completed

A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients

NCT00398996

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations: CAPRISA eThekwini Clinical Research Site Durban, KwaZulu-Natal, South Africa

View Trial Details

Completed

Genetics of Progressive Multifocal Leukoencephalopathy and Acquired Immunodeficiency Syndrome

NCT00342602

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +16 more
Locations: University of California, Los Angeles Los Angeles, California, United States

Northwestern University Chicago, Illinois, United States

John H. Stroger, Jr. Hospital of Cook County Chicago, Illinois, United States

Howard Brown Health Center Chicago, Illinois, United States

View Trial Details

Completed

Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy

NCT00001477

Conditions: Communicable Diseases, Disease Attributes, Infections, +3 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Opportunistic Infections

Opportunistic Infections trial results

Related conditions